Agenus, Inc.

At Agenus (NASDAQ: AGEN), we believe the best path for treating disease is through activating our own body’s natural mechanisms. That’s why for 20 years, we’ve focused on building technologies and a product pipeline aimed at treating cancers and infection by helping the body’s immune system to target diseased cells with precision. We believe in the power of science. The body’s immune system is the single most effective tool we have to protect us from disease and help us fight disease when we get sick. At Agenus, we believe that by activating our body’s own natural mechanisms, using scientifically sound tools, we aim to help the body heal itself. Our quest for science-focused solutions started in 1994. Nearly 20 years later, we remain committed to delivering on the promise of immunology to treat cancers and infectious diseases. Agenus is gratified to be part of several important clinical development programs. We’re proud of the deep convictions and commitment we share with our growing circle of partners and collaborators to alleviate the burden of diseases and the burden of treatment.